Neal Flomenberg

TitleEmeritus Faculty
InstitutionThomas Jefferson University
DepartmentMedical Oncology
Address233 S. 10th Street
Philadelphia PA 19107
Phone215-955-9642
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Bi X, Grosso D, Gradone A, Filicko-O'Hara J, Mccorkell K, O'Hara W, Wagner JL, Flomenberg N, Gergis U. A Tender RIC for the Unfit: A Novel 4 Gy TBI-based Conditioning Followed by Two-step Haploidentical Stem Cell transplant, Results of a Prospective Trial. Transplant Cell Ther. 2024 Jul 29. PMID: 39084263.
      Citations:    
    2. Grosso D, Wagner JL, O'Connor A, Keck K, Huang Y, Wang ZX, Mehler H, Leiby B, Flomenberg P, Gergis U, Nikbakht N, Morris M, Karp JK, Peedin A, Flomenberg N. Safety and Feasibility of Third-Party Cytotoxic T Lymphocytes for High-Risk Patients with Covid-19. Blood Adv. 2024 Jun 17. PMID: 38885482.
      Citations:    
    3. Jeurkar C, Leiby B, Rashid S, Gergis U, Grossso D, Carabasi M, Filicko-O'Hara J, O'Hara W, Klumpp T, Porcu P, Flomenberg N, Wagner JL. A prospective study of posttransplant cyclophosphamide for unrelated donor peripheral blood stem cell transplant with special attention to graft content and the impact of a higher ?d T cell dose. Eur J Haematol. 2024 May 06. PMID: 38711359.
      Citations:    
    4. Grosso D, Leiby B, Wilde L, Carabasi M, Filicko-O'Hara J, O'Hara W, Wagner JL, Mateja G, Alpdogan O, Binder A, Kasner M, Keiffer G, Klumpp T, Martinez UO, Palmisiano N, Porcu P, Gergis U, Flomenberg N. A Prospective, Randomized Trial Examining the Use of G-CSF Versus No G-CSF in Patients Post-Autologous Transplantation. Transplant Cell Ther. 2022 12; 28(12):831.e1-831.e7. PMID: 36167307.
      Citations:    
    5. Bi X, Gergis U, Wagner JL, Carabasi M, Filicko-O'Hara J, O'Hara W, Klumpp T, Porcu P, Flomenberg N, Grosso D. Outcomes of two-step haploidentical allogeneic stem cell transplantation in elderly patients with hematologic malignancies. Bone Marrow Transplant. 2022 11; 57(11):1671-1680. PMID: 35986105.
      Citations:    
    6. Yang Y, Gergis U, Carabasi M, Filicko-O'Hara J, Wagner JL, O'Hara W, Binder A, Alpdogan O, Martinez-Outschoorn U, Porcu P, Flomenberg N, Grosso D. The Two-Step Allogeneic Stem Cell Transplantation Approach Results in Rapid Engraftment and Excellent Outcomes in Patients with Lymphoid Malignancies. Transplant Cell Ther. 2021 Dec 24. PMID: 34954295.
      Citations:    
    7. Bi X, Beadle D, Xu A, Neff J, DeGregorio N, Odeh M, McNair C, Grosso D, Porcu P, Gergis U, Flomenberg N, Klumpp TR. Design and Implementation of a Multipurpose Information System for Hematopoietic Stem-Cell Transplantation on the Basis of the Biomedical Research Integrated Domain Group Model. JCO Clin Cancer Inform. 2021 Oct; 5:1076-1084. PMID: 34726955.
      Citations:    
    8. Myers RE, Advani SM, Myers P, Selvan P, Garber G, Worster B, Flomenberg N, Chapman A, Zinner R. Engaging Patients with Late-Stage Non-Small Cell Lung Cancer in Shared Decision Making about Treatment. J Pers Med. 2021 Oct 01; 11(10). PMID: 34683140.
      Citations:    
    9. Jeurkar C, Leiby B, Banks J, Leader A, Rudolph S, Mateja G, Rashid SA, Carabasi M, Filicko-O'Hara J, O'Hara W, Wagner JL, Gergis U, Flomenberg N, Grosso D. An Examination of Cytomegalovirus, Socioeconomic Status, Race, and Ethnicity on Outcomes after Haploidentical Hematopoietic Transplantation. Transplant Cell Ther. 2021 Apr; 27(4):327.e1-327.e11. PMID: 33836876.
      Citations:    
    10. Pan J, Ghimire S, Alpdogan SO, Chapman A, Carabasi M, DiMeglio M, Gong J, Martinez-Outschoorn U, Rose L, Ramirez M, Wagner JL, Weiss M, Flomenberg N, Pro B, Porcu P, Filicko-OHara J, Gaballa S. Phase I/II study of bendamustine in combination with ofatumumab, carboplatin, etoposide (BOCE) for relapsed or refractory aggressive B-cell non-Hodgkin lymphoma. Leuk Lymphoma. 2020 Nov 04; 1-8. PMID: 33146052.
      Citations:    
    11. Grosso D, Carabasi M, Filicko-O'Hara J, Wagner JL, O'Hara W, Sun M, Colombe B, Shi W, Werner-Wasik M, Rudolph S, Alpdogan O, Binder A, Kasner M, Klumpp T, Martinez-Outschoorn U, Palmisiano N, Wilde L, Porcu P, Gergis U, Flomenberg N. Low Nonrelapse Mortality after HLA-Matched Related 2-Step Hematopoietic Stem Cell Transplantation Using Cyclophosphamide for Graft-versus-Host Disease Prophylaxis and the Potential Impact of Non- Cyclophosphamide-Exposed T Cells on Outcomes. Biol Blood Marrow Transplant. 2020 Jul 03. PMID: 32629157.
      Citations:    
    12. Calafiore R, Mouchtouris N, Flomenberg N, Harrop JS. Epstein-Barr Virus-Associated Smooth Muscle Tumor of the Spine After Bone Marrow Transplant: Case Report and Review of Literature. World Neurosurg. 2019 Dec 03; 135:192-196. PMID: 31809898.
      Citations:    
    13. Grosso D, Leiby B, Carabasi M, Filicko-O'Hara J, Gaballa S, O'Hara W, Wagner JL, Flomenberg N. The Presence of a CMV Immunodominant Allele in the Recipient Is Associated With Increased Survival in CMV Positive Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplantation. Front Oncol. 2019; 9:888. PMID: 31608225.
      Citations:    
    14. Amarasekera D, Connolly D, Gochoco A, Yang S, Grosso D, Flomenberg N, Shi W, Alpdogan SO, Duffy R, Sahu J. Cutaneous B-Cell Lymphoblastic Lymphoma. Am J Dermatopathol. 2019 Aug; 41(8):596-601. PMID: 31335415.
      Citations:    
    15. Hari P, Reece DE, Randhawa J, Flomenberg N, Howard DS, Badros AZ, Rapoport AP, Meisenberg BR, Filicko-Ohara J, Phillips GL, Vesole DH. Final outcomes of escalated melphalan 280?mg/m2 with amifostine cytoprotection followed autologous hematopoietic stem cell transplantation for multiple myeloma: high CR and VGPR rates do not translate into improved survival. Bone Marrow Transplant. 2018 Jun 15. PMID: 29907806.
      Citations:    
    16. Kasner MT, Mick R, Jeschke GR, Carabasi M, Filicko-O'Hara J, Flomenberg N, Frey NV, Hexner EO, Luger SM, Loren AW, Mangan JK, Wagner JL, Weiss M, Carroll M, Perl AE. Sirolimus enhances remission induction in patients with high risk acute myeloid leukemia and mTORC1 target inhibition. Invest New Drugs. 2018 Apr 02. PMID: 29607465.
      Citations:    
    17. Geethakumari PR, Leiby B, Nair R, Alpdogan SO, Carabasi M, Filicko-O'Hara J, Gaballa S, Kasner M, Klumpp T, Martinez-Outschoorn U, Palmisiano N, Wagner JL, Porcu P, Flomenberg N, Grosso D. Higher rates of relapse in maternal recipients of haploidentical hematopoietic stem cell transplantation from adult offspring donors for AML and myelodysplastic syndrome. Bone Marrow Transplant. 2017 10; 52(10):1465-1467. PMID: 28759027.
      Citations:    
    18. Bailey CP, Budak-Alpdogan T, Sauter CT, Panis MM, Buyukgoz C, Jeng EK, Wong HC, Flomenberg N, Alpdogan O. New interleukin-15 superagonist (IL-15SA) significantly enhances graft-versus-tumor activity. Oncotarget. 2017 Jul 04; 8(27):44366-44378. PMID: 28574833.
      Citations:    
    19. Pan J, Chen J, Filicko J, Grosso D, Nagurney M, Alpdogan O, Flomenberg N. Relapsed Multiple Myeloma Presenting as Intracranial Plasmacytoma and Malignant Pericardial Effusion following Recent Allogeneic Stem Cell Transplantation. Case Rep Oncol. 2017 May-Aug; 10(2):582-587. PMID: 28868016.
      Citations:    
    20. Petruk S, Mariani SA, De Dominici M, Porazzi P, Minieri V, Cai J, Iacovitti L, Flomenberg N, Calabretta B, Mazo A. Structure of Nascent Chromatin Is Essential for Hematopoietic Lineage Specification. Cell Rep. 2017 Apr 11; 19(2):295-306. PMID: 28402853.
      Citations:    
    21. Grosso D, Johnson E, Colombe B, Alpdogan O, Carabasi M, Filicko-O'Hara J, Gaballa S, Kasner M, Klumpp T, Martinez-Outschoorn U, Wagner JL, Weiss M, Wang Z, Flomenberg N. Acquired uniparental disomy in chromosome 6p as a feature of relapse after T-cell replete haploidentical hematopoietic stem cell transplantation using cyclophosphamide tolerization. Bone Marrow Transplant. 2017 Apr; 52(4):615-619. PMID: 28067885.
      Citations:    
    22. Anikeeva N, Grosso D, Flomenberg N, Sykulev Y. Evaluating frequency and quality of pathogen-specific T cells. Nat Commun. 2016 Oct 27; 7:13264. PMID: 27786275.
      Citations:    
    23. Gaballa S, Palmisiano N, Alpdogan O, Carabasi M, Filicko-O'Hara J, Kasner M, Kraft WK, Leiby B, Martinez-Outschoorn U, O'Hara W, Pro B, Rudolph S, Sharma M, Wagner JL, Weiss M, Flomenberg N, Grosso D. A Two-Step Haploidentical Versus a Two-Step Matched Related Allogeneic Myeloablative Peripheral Blood Stem Cell Transplantation. Biol Blood Marrow Transplant. 2016 Jan; 22(1):141-8. PMID: 26415558.
      Citations:    
    24. Grosso D, Gaballa S, Alpdogan O, Carabasi M, Filicko-O'Hara J, Kasner M, Martinez-Outschoorn U, Wagner JL, O'Hara W, Rudolph S, Chervoneva I, Colombe B, Farley PC, Flomenberg P, Pro B, Sharma M, Shi W, Weiss M, Flomenberg N. A two-step approach to myeloablative haploidentical transplantation: low nonrelapse mortality and high survival confirmed in patients with earlier stage disease. Biol Blood Marrow Transplant. 2015 Apr; 21(4):646-52. PMID: 25542159.
      Citations:    
    25. Bruminhent J, Wang ZX, Hu C, Wagner J, Sunday R, Bobik B, Hegarty S, Keith S, Alpdogan S, Carabasi M, Filicko-O'Hara J, Flomenberg N, Kasner M, Outschoorn UM, Weiss M, Flomenberg P. Clostridium difficile colonization and disease in patients undergoing hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2014 Sep; 20(9):1329-34. PMID: 24792871.
      Citations:    
    26. Alpdogan O, Grosso D, Flomenberg N. Recent advances in haploidentical stem cell transplantation. Discov Med. 2013 Oct; 16(88):159-65. PMID: 24099671.
      Citations:    
    27. Martinez-Outschoorn UE, Whitaker-Menezes D, Valsecchi M, Martinez-Cantarin MP, Dulau-Florea A, Gong J, Howell A, Flomenberg N, Pestell RG, Wagner J, Arana-Yi C, Sharma M, Sotgia F, Lisanti MP. Reverse warburg effect in a patient with aggressive B-cell lymphoma: is lactic acidosis a paraneoplastic syndrome? Semin Oncol. 2013 Aug; 40(4):403-18. PMID: 23972703.
      Citations:    
    28. Sauter CT, Bailey CP, Panis MM, Biswas CS, Budak-Alpdogan T, Durham A, Flomenberg N, Alpdogan O. Interleukin-15 administration increases graft-versus-tumor activity in recipients of haploidentical hematopoietic SCT. Bone Marrow Transplant. 2013 Sep; 48(9):1237-42. PMID: 23624821.
      Citations:    
    29. Fernández-Viña MA, Klein JP, Haagenson M, Spellman SR, Anasetti C, Noreen H, Baxter-Lowe LA, Cano P, Flomenberg N, Confer DL, Horowitz MM, Oudshoorn M, Petersdorf EW, Setterholm M, Champlin R, Lee SJ, de Lima M. Multiple mismatches at the low expression HLA loci DP, DQ, and DRB3/4/5 associate with adverse outcomes in hematopoietic stem cell transplantation. Blood. 2013 May 30; 121(22):4603-10. PMID: 23596045.
      Citations:    
    30. Budak-Alpdogan T, Sauter CT, Bailey CP, Biswas CS, Panis MM, Civriz S, Flomenberg N, Alpdogan O. Haploidentical hematopoietic SCT increases graft-versus-tumor effect against renal cell carcinoma. Bone Marrow Transplant. 2013 Aug; 48(8):1084-90. PMID: 23435516.
      Citations:    
    31. Flomenberg N. Introduction: haploidentical bone marrow transplantation. Semin Oncol. 2012 Dec; 39(6):627-8. PMID: 23206839.
      Citations:    
    32. Grosso D, Flomenberg N. A two-step approach to allogeneic haploidentical hematopoietic stem cell transplantation. Semin Oncol. 2012 Dec; 39(6):694-706. PMID: 23206846.
      Citations:    
    33. Biswas CS, Sauter CT, Bailey CP, Rittenberg D, Luo X, Panis MM, Budak-Alpdogan T, Grosso D, Flomenberg N, Alpdogan O. Double Haploidentical Hematopoietic Stem Cell Transplantation Results in Successful Engraftment of Bone Marrow from Both Donors without Graft-versus-Host or Graft-versus-Graft Effects. Biol Blood Marrow Transplant. 2012 Dec; 18(12):1808-18. PMID: 23084958.
      Citations:    
    34. Sotgia F, Whitaker-Menezes D, Martinez-Outschoorn UE, Flomenberg N, Birbe RC, Witkiewicz AK, Howell A, Philp NJ, Pestell RG, Lisanti MP. Mitochondrial metabolism in cancer metastasis: visualizing tumor cell mitochondria and the "reverse Warburg effect" in positive lymph node tissue. Cell Cycle. 2012 Apr 1; 11(7):1445-54. PMID: 22395432.
      Citations:    
    35. Ko YH, Lin Z, Flomenberg N, Pestell RG, Howell A, Sotgia F, Lisanti MP, Martinez-Outschoorn UE. Glutamine fuels a vicious cycle of autophagy in the tumor stroma and oxidative mitochondrial metabolism in epithelial cancer cells: Implications for preventing chemotherapy resistance. Cancer Biol Ther. 2011 Dec 15; 12(12):1085-97. PMID: 22236876.
      Citations:    
    36. Whitaker-Menezes D, Martinez-Outschoorn UE, Flomenberg N, Birbe RC, Witkiewicz AK, Howell A, Pavlides S, Tsirigos A, Ertel A, Pestell RG, Broda P, Minetti C, Lisanti MP, Sotgia F. Hyperactivation of oxidative mitochondrial metabolism in epithelial cancer cells in situ: visualizing the therapeutic effects of metformin in tumor tissue. Cell Cycle. 2011 Dec 1; 10(23):4047-64. PMID: 22134189.
      Citations:    
    37. Martinez-Outschoorn UE, Goldberg A, Lin Z, Ko YH, Flomenberg N, Wang C, Pavlides S, Pestell RG, Howell A, Sotgia F, Lisanti MP. Anti-estrogen resistance in breast cancer is induced by the tumor microenvironment and can be overcome by inhibiting mitochondrial function in epithelial cancer cells. Cancer Biol Ther. 2011 Nov 15; 12(10):924-38. PMID: 22041887.
      Citations:    
    38. Grosso D, Carabasi M, Filicko-O'Hara J, Kasner M, Wagner JL, Colombe B, Cornett Farley P, O'Hara W, Flomenberg P, Werner-Wasik M, Brunner J, Mookerjee B, Hyslop T, Weiss M, Flomenberg N. A 2-step approach to myeloablative haploidentical stem cell transplantation: a phase 1/2 trial performed with optimized T-cell dosing. Blood. 2011 Oct 27; 118(17):4732-9. PMID: 21868572.
      Citations:    
    39. Martinez-Outschoorn UE, Lin Z, Ko YH, Goldberg AF, Flomenberg N, Wang C, Pavlides S, Pestell RG, Howell A, Sotgia F, Lisanti MP. Understanding the metabolic basis of drug resistance: therapeutic induction of the Warburg effect kills cancer cells. Cell Cycle. 2011 Aug 1; 10(15):2521-8. PMID: 21768775.
      Citations:    
    40. Martinez-Outschoorn UE, Lin Z, Trimmer C, Flomenberg N, Wang C, Pavlides S, Pestell RG, Howell A, Sotgia F, Lisanti MP. Cancer cells metabolically "fertilize" the tumor microenvironment with hydrogen peroxide, driving the Warburg effect: implications for PET imaging of human tumors. Cell Cycle. 2011 Aug 1; 10(15):2504-20. PMID: 21778829.
      Citations:    
    41. Whitaker-Menezes D, Martinez-Outschoorn UE, Lin Z, Ertel A, Flomenberg N, Witkiewicz AK, Birbe RC, Howell A, Pavlides S, Gandara R, Pestell RG, Sotgia F, Philp NJ, Lisanti MP. Evidence for a stromal-epithelial "lactate shuttle" in human tumors: MCT4 is a marker of oxidative stress in cancer-associated fibroblasts. Cell Cycle. 2011 Jun 1; 10(11):1772-83. PMID: 21558814.
      Citations:    
    42. Martinez-Outschoorn UE, Whitaker-Menezes D, Lin Z, Flomenberg N, Howell A, Pestell RG, Lisanti MP, Sotgia F. Cytokine production and inflammation drive autophagy in the tumor microenvironment: role of stromal caveolin-1 as a key regulator. Cell Cycle. 2011 Jun 1; 10(11):1784-93. PMID: 21566463.
      Citations:    
    43. Martinez-Outschoorn UE, Prisco M, Ertel A, Tsirigos A, Lin Z, Pavlides S, Wang C, Flomenberg N, Knudsen ES, Howell A, Pestell RG, Sotgia F, Lisanti MP. Ketones and lactate increase cancer cell "stemness," driving recurrence, metastasis and poor clinical outcome in breast cancer: achieving personalized medicine via Metabolo-Genomics. Cell Cycle. 2011 Apr 15; 10(8):1271-86. PMID: 21512313.
      Citations:    
    44. Martinez-Outschoorn UE, Whitaker-Menezes D, Pavlides S, Chiavarina B, Bonuccelli G, Casey T, Tsirigos A, Migneco G, Witkiewicz A, Balliet R, Mercier I, Wang C, Flomenberg N, Howell A, Lin Z, Caro J, Pestell RG, Sotgia F, Lisanti MP. The autophagic tumor stroma model of cancer or "battery-operated tumor growth": A simple solution to the autophagy paradox. Cell Cycle. 2010 Nov 1; 9(21):4297-306. PMID: 21051947.
      Citations:    
    45. Woolfrey A, Klein JP, Haagenson M, Spellman S, Petersdorf E, Oudshoorn M, Gajewski J, Hale GA, Horan J, Battiwalla M, Marino SR, Setterholm M, Ringden O, Hurley C, Flomenberg N, Anasetti C, Fernandez-Vina M, Lee SJ. HLA-C antigen mismatch is associated with worse outcome in unrelated donor peripheral blood stem cell transplantation. Biol Blood Marrow Transplant. 2011 Jun; 17(6):885-92. PMID: 20870028.
      Citations:    
    46. Bonuccelli G, Tsirigos A, Whitaker-Menezes D, Pavlides S, Pestell RG, Chiavarina B, Frank PG, Flomenberg N, Howell A, Martinez-Outschoorn UE, Sotgia F, Lisanti MP. Ketones and lactate "fuel" tumor growth and metastasis: Evidence that epithelial cancer cells use oxidative mitochondrial metabolism. Cell Cycle. 2010 Sep 1; 9(17):3506-14. PMID: 20818174.
      Citations:    
    47. Martinez-Outschoorn UE, Trimmer C, Lin Z, Whitaker-Menezes D, Chiavarina B, Zhou J, Wang C, Pavlides S, Martinez-Cantarin MP, Capozza F, Witkiewicz AK, Flomenberg N, Howell A, Pestell RG, Caro J, Lisanti MP, Sotgia F. Autophagy in cancer associated fibroblasts promotes tumor cell survival: Role of hypoxia, HIF1 induction and NF?B activation in the tumor stromal microenvironment. Cell Cycle. 2010 Sep 1; 9(17):3515-33. PMID: 20855962.
      Citations:    
    48. Pavlides S, Tsirigos A, Migneco G, Whitaker-Menezes D, Chiavarina B, Flomenberg N, Frank PG, Casimiro MC, Wang C, Pestell RG, Martinez-Outschoorn UE, Howell A, Sotgia F, Lisanti MP. The autophagic tumor stroma model of cancer: Role of oxidative stress and ketone production in fueling tumor cell metabolism. Cell Cycle. 2010 Sep 1; 9(17):3485-505. PMID: 20861672.
      Citations:    
    49. Martinez-Outschoorn UE, Balliet RM, Rivadeneira DB, Chiavarina B, Pavlides S, Wang C, Whitaker-Menezes D, Daumer KM, Lin Z, Witkiewicz AK, Flomenberg N, Howell A, Pestell RG, Knudsen ES, Sotgia F, Lisanti MP. Oxidative stress in cancer associated fibroblasts drives tumor-stroma co-evolution: A new paradigm for understanding tumor metabolism, the field effect and genomic instability in cancer cells. Cell Cycle. 2010 Aug 15; 9(16):3256-76. PMID: 20814239.
      Citations:    
    50. Martinez-Outschoorn UE, Pavlides S, Whitaker-Menezes D, Daumer KM, Milliman JN, Chiavarina B, Migneco G, Witkiewicz AK, Martinez-Cantarin MP, Flomenberg N, Howell A, Pestell RG, Lisanti MP, Sotgia F. Tumor cells induce the cancer associated fibroblast phenotype via caveolin-1 degradation: implications for breast cancer and DCIS therapy with autophagy inhibitors. Cell Cycle. 2010 Jun 15; 9(12):2423-33. PMID: 20562526.
      Citations:    
    51. Migneco G, Whitaker-Menezes D, Chiavarina B, Castello-Cros R, Pavlides S, Pestell RG, Fatatis A, Flomenberg N, Tsirigos A, Howell A, Martinez-Outschoorn UE, Sotgia F, Lisanti MP. Glycolytic cancer associated fibroblasts promote breast cancer tumor growth, without a measurable increase in angiogenesis: evidence for stromal-epithelial metabolic coupling. Cell Cycle. 2010 Jun 15; 9(12):2412-22. PMID: 20562527.
      Citations:    
    52. Pavlides S, Tsirigos A, Vera I, Flomenberg N, Frank PG, Casimiro MC, Wang C, Fortina P, Addya S, Pestell RG, Martinez-Outschoorn UE, Sotgia F, Lisanti MP. Loss of stromal caveolin-1 leads to oxidative stress, mimics hypoxia and drives inflammation in the tumor microenvironment, conferring the "reverse Warburg effect": a transcriptional informatics analysis with validation. Cell Cycle. 2010 Jun 1; 9(11):2201-19. PMID: 20519932.
      Citations:    
    53. Bonuccelli G, Whitaker-Menezes D, Castello-Cros R, Pavlides S, Pestell RG, Fatatis A, Witkiewicz AK, Vander Heiden MG, Migneco G, Chiavarina B, Frank PG, Capozza F, Flomenberg N, Martinez-Outschoorn UE, Sotgia F, Lisanti MP. The reverse Warburg effect: glycolysis inhibitors prevent the tumor promoting effects of caveolin-1 deficient cancer associated fibroblasts. Cell Cycle. 2010 May 15; 9(10):1960-71. PMID: 20495363.
      Citations:    
    54. Pavlides S, Tsirigos A, Vera I, Flomenberg N, Frank PG, Casimiro MC, Wang C, Pestell RG, Martinez-Outschoorn UE, Howell A, Sotgia F, Lisanti MP. Transcriptional evidence for the "Reverse Warburg Effect" in human breast cancer tumor stroma and metastasis: similarities with oxidative stress, inflammation, Alzheimer's disease, and "Neuron-Glia Metabolic Coupling". Aging (Albany NY). 2010 Apr; 2(4):185-99. PMID: 20442453.
      Citations:    
    55. Flomenberg N, Comenzo RL, Badel K, Calandra G. Plerixafor (Mozobil) alone to mobilize hematopoietic stem cells from multiple myeloma patients for autologous transplantation. Biol Blood Marrow Transplant. 2010 May; 16(5):695-700. PMID: 20067838.
      Citations:    
    56. Jiao X, Katiyar S, Willmarth NE, Liu M, Ma X, Flomenberg N, Lisanti MP, Pestell RG. c-Jun induces mammary epithelial cellular invasion and breast cancer stem cell expansion. J Biol Chem. 2010 Mar 12; 285(11):8218-26. PMID: 20053993.
      Citations:    
    57. Pavlides S, Whitaker-Menezes D, Castello-Cros R, Flomenberg N, Witkiewicz AK, Frank PG, Casimiro MC, Wang C, Fortina P, Addya S, Pestell RG, Martinez-Outschoorn UE, Sotgia F, Lisanti MP. The reverse Warburg effect: aerobic glycolysis in cancer associated fibroblasts and the tumor stroma. Cell Cycle. 2009 Dec; 8(23):3984-4001. PMID: 19923890.
      Citations:    
    58. Filicko-O'Hara J, Grosso D, Flomenberg PR, Friedman TM, Brunner J, Drobyski W, Ferber A, Kakhniashvili I, Keever-Taylor C, Mookerjee B, Talano JA, Wagner JI, Korngold R, Flomenberg N. Antiviral responses following L-leucyl-L-leucine methyl esther (LLME)-treated lymphocyte infusions: graft-versus-infection without graft-versus-host disease. Biol Blood Marrow Transplant. 2009 Dec; 15(12):1609-19. PMID: 19744572.
      Citations:    
    59. Bonuccelli G, Casimiro MC, Sotgia F, Wang C, Liu M, Katiyar S, Zhou J, Dew E, Capozza F, Daumer KM, Minetti C, Milliman JN, Alpy F, Rio MC, Tomasetto C, Mercier I, Flomenberg N, Frank PG, Pestell RG, Lisanti MP. Caveolin-1 (P132L), a common breast cancer mutation, confers mammary cell invasiveness and defines a novel stem cell/metastasis-associated gene signature. Am J Pathol. 2009 May; 174(5):1650-62. PMID: 19395651.
      Citations:    
    60. Mercier I, Jasmin JF, Pavlides S, Minetti C, Flomenberg N, Pestell RG, Frank PG, Sotgia F, Lisanti MP. Clinical and translational implications of the caveolin gene family: lessons from mouse models and human genetic disorders. Lab Invest. 2009 Jun; 89(6):614-23. PMID: 19333235.
      Citations:    
    61. Joshi A, Tang J, Kuzma M, Wagner J, Mookerjee B, Filicko J, Carabasi M, Flomenberg N, Flomenberg P. Adenovirus DNA polymerase is recognized by human CD8+ T cells. J Gen Virol. 2009 Jan; 90(Pt 1):84-94. PMID: 19088277.
      Citations:    
    62. Vesole DH, Zhang L, Flomenberg N, Greipp PR, Lazarus HM, Huff CA. A Phase II trial of autologous stem cell transplantation followed by mini-allogeneic stem cell transplantation for the treatment of multiple myeloma: an analysis of Eastern Cooperative Oncology Group ECOG E4A98 and E1A97. Biol Blood Marrow Transplant. 2009 Jan; 15(1):83-91. PMID: 19135946.
      Citations:    
    63. Cherian D, Braun K, Flomenberg N, Palazzo J, Kastenberg D. Complete resolution of gastric amyloidosis after autologous stem cell transplantation. Endoscopy. 2008 Sep; 40 Suppl 2:E167-8. PMID: 18668456.
      Citations:    
    64. Friedman TM, Goldgirsh K, Berger SA, Zilberberg J, Filicko-O'Hara J, Flomenberg N, Donato M, Rowley SD, Korngold R. Overlap between in vitro donor antihost and in vivo posttransplantation TCR Vbeta use: a new paradigm for designer allogeneic blood and marrow transplantation. Blood. 2008 Oct 15; 112(8):3517-25. PMID: 18541718.
      Citations:    
    65. Garzon R, Volinia S, Liu CG, Fernandez-Cymering C, Palumbo T, Pichiorri F, Fabbri M, Coombes K, Alder H, Nakamura T, Flomenberg N, Marcucci G, Calin GA, Kornblau SM, Kantarjian H, Bloomfield CD, Andreeff M, Croce CM. MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia. Blood. 2008 Mar 15; 111(6):3183-9. PMID: 18187662.
      Citations:    
    66. Friedman TM, Filicko-O'Hara J, Mookerjee B, Wagner JL, Grosso DA, Flomenberg N, Korngold R. T cell repertoire complexity is conserved after LLME treatment of donor lymphocyte infusions. Biol Blood Marrow Transplant. 2007 Dec; 13(12):1439-47. PMID: 18022573.
      Citations:    
    67. Li J, Mookerjee B, Wagner J, Flomenberg N. In vitro methods for generating highly purified EBV associated tumor antigen-specific T cells by using solid phase T cell selection system for immunotherapy. J Immunol Methods. 2007 Dec 1; 328(1-2):169-81. PMID: 17931649.
      Citations:    
    68. Lee SJ, Klein J, Haagenson M, Baxter-Lowe LA, Confer DL, Eapen M, Fernandez-Vina M, Flomenberg N, Horowitz M, Hurley CK, Noreen H, Oudshoorn M, Petersdorf E, Setterholm M, Spellman S, Weisdorf D, Williams TM, Anasetti C. High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation. Blood. 2007 Dec 15; 110(13):4576-83. PMID: 17785583.
      Citations:    
    69. Neofytos D, Ojha A, Mookerjee B, Wagner J, Filicko J, Ferber A, Dessain S, Grosso D, Brunner J, Flomenberg N, Flomenberg P. Treatment of adenovirus disease in stem cell transplant recipients with cidofovir. Biol Blood Marrow Transplant. 2007 Jan; 13(1):74-81. PMID: 17222755.
      Citations:    
    70. Tsai SC, Reale LD, Flomenberg N, Schwarting R, Enck RE. Alveolar rhabdomyosarcoma mimicking a lymphoma at presentation. J Clin Oncol. 2006 Aug 20; 24(24):4031-2. PMID: 16921060.
      Citations:    
    71. Tang J, Olive M, Pulmanausahakul R, Schnell M, Flomenberg N, Eisenlohr L, Flomenberg P. Human CD8+ cytotoxic T cell responses to adenovirus capsid proteins. Virology. 2006 Jul 5; 350(2):312-22. PMID: 16499941.
      Citations:    
    72. Kakhniashvili I, Filicko J, Kraft WK, Flomenberg N. Heterogeneous clearance of antithymocyte globulin after CD34+-selected allogeneic hematopoietic progenitor cell transplantation. Biol Blood Marrow Transplant. 2005 Aug; 11(8):609-18. PMID: 16041311.
      Citations:    
    73. Flomenberg N, Devine SM, Dipersio JF, Liesveld JL, McCarty JM, Rowley SD, Vesole DH, Badel K, Calandra G. The use of AMD3100 plus G-CSF for autologous hematopoietic progenitor cell mobilization is superior to G-CSF alone. Blood. 2005 Sep 1; 106(5):1867-74. PMID: 15890685.
      Citations:    
    74. Shaughnessy PJ, Bachier C, Grimley M, Freytes CO, Callander NS, Essell JH, Flomenberg N, Selby G, Lemaistre CF. Denileukin diftitox for the treatment of steroid-resistant acute graft-versus-host disease. Biol Blood Marrow Transplant. 2005 Mar; 11(3):188-93. PMID: 15744237.
      Citations:    
    75. Flomenberg N, DiPersio J, Calandra G. Role of CXCR4 chemokine receptor blockade using AMD3100 for mobilization of autologous hematopoietic progenitor cells. Acta Haematol. 2005; 114(4):198-205. PMID: 16269859.
      Citations:    
    76. Grosso D, Filicko J, Garcia-Manero G, Beardell F, Brunner J, Cohn J, Ferbér A, Martinez J, Mookerjee B, Rose L, Tice D, Wagner JL, Capizzi R, Flomenberg N. Cytoprotection in acute myelogenous leukemia (AML) therapy. Semin Oncol. 2004 Dec; 31(6 Suppl 18):67-73. PMID: 15726527.
      Citations:    
    77. Tang J, Olive M, Champagne K, Flomenberg N, Eisenlohr L, Hsu S, Flomenberg P. Adenovirus hexon T-cell epitope is recognized by most adults and is restricted by HLA DP4, the most common class II allele. Gene Ther. 2004 Sep; 11(18):1408-15. PMID: 15269714.
      Citations:    
    78. Phillips GL, Meisenberg B, Reece DE, Adams VR, Badros A, Brunner J, Fenton R, Filicko J, Grosso D, Hale GA, Howard DS, Johnson VP, Kniska A, Marshall KW, Nath R, Reed E, Rapoport AP, Takebe N, Vesole DH, Wagner JL, Flomenberg N. Amifostine and autologous hematopoietic stem cell support of escalating-dose melphalan: a phase I study. Biol Blood Marrow Transplant. 2004 Jul; 10(7):473-83. PMID: 15205668.
      Citations:    
    79. Flomenberg N, Baxter-Lowe LA, Confer D, Fernandez-Vina M, Filipovich A, Horowitz M, Hurley C, Kollman C, Anasetti C, Noreen H, Begovich A, Hildebrand W, Petersdorf E, Schmeckpeper B, Setterholm M, Trachtenberg E, Williams T, Yunis E, Weisdorf D. Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome. Blood. 2004 Oct 1; 104(7):1923-30. PMID: 15191952.
      Citations:    
    80. Phillips GL, Meisenberg BR, Reece DE, Adams VR, Badros AZ, Brunner JL, Fenton RG, Filicko J, Grosso DL, Hale GA, Howard DS, Johnson VP, Kniska A, Marshall KW, Mookerjee B, Nath R, Rapoport AP, Sarkodee-Adoo C, Takebe N, Vesole DH, Wagner JL, Flomenberg N. Activity of single-agent melphalan 220-300 mg/m2 with amifostine cytoprotection and autologous hematopoietic stem cell support in non-Hodgkin and Hodgkin lymphoma. Bone Marrow Transplant. 2004 Apr; 33(8):781-7. PMID: 14767498.
      Citations:    
    81. Devine SM, Flomenberg N, Vesole DH, Liesveld J, Weisdorf D, Badel K, Calandra G, DiPersio JF. Rapid mobilization of CD34+ cells following administration of the CXCR4 antagonist AMD3100 to patients with multiple myeloma and non-Hodgkin's lymphoma. J Clin Oncol. 2004 Mar 15; 22(6):1095-102. PMID: 15020611.
      Citations:    
    82. Filicko J, Lazarus HM, Flomenberg N. Mucosal injury in patients undergoing hematopoietic progenitor cell transplantation: new approaches to prophylaxis and treatment. Bone Marrow Transplant. 2003 Jan; 31(1):1-10. PMID: 12621500.
      Citations:    
    83. Olive M, Eisenlohr L, Flomenberg N, Hsu S, Flomenberg P. The adenovirus capsid protein hexon contains a highly conserved human CD4+ T-cell epitope. Hum Gene Ther. 2002 Jul 1; 13(10):1167-78. PMID: 12133270.
      Citations:    
    84. Drobyski WR, Klein J, Flomenberg N, Pietryga D, Vesole DH, Margolis DA, Keever-Taylor CA. Superior survival associated with transplantation of matched unrelated versus one-antigen-mismatched unrelated or highly human leukocyte antigen-disparate haploidentical family donor marrow grafts for the treatment of hematologic malignancies: establishing a treatment algorithm for recipients of alternative donor grafts. Blood. 2002 Feb 1; 99(3):806-14. PMID: 11806980.
      Citations:    
    85. Hsieh MH, Varadi G, Flomenberg N, Korngold R. Leucyl-leucine methyl ester-treated haploidentical donor lymphocyte infusions can mediate graft-versus-leukemia activity with minimal graft-versus-host disease risk. Biol Blood Marrow Transplant. 2002; 8(6):303-15. PMID: 12108916.
      Citations:    
    86. Friedman TM, Varadi G, Hopely DD, Filicko J, Wagner J, Ferber A, Martinez J, Brunner J, Grosso D, McGuire L, Korngold R, Flomenberg N. Nonmyeloablative conditioning allows for more rapid T-cell repertoire reconstitution following allogeneic matched unrelated bone marrow transplantation compared to myeloablative approaches. Biol Blood Marrow Transplant. 2001; 7(12):656-64. PMID: 11787528.
      Citations:    
    87. Hsu SH, Robbins FM, Modelo RB, Brunner J, Flomenberg N. Identification of a new DQB1*0613 allele in a family. Tissue Antigens. 1997 Dec; 50(6):685-7. PMID: 9458130.
      Citations:    
    88. Kawanishi Y, Passweg J, Drobyski WR, Rowlings P, Cook-Craig A, Casper J, Pietryga D, Garbrecht F, Camitta B, Horowitz M, Juckett M, Margolis D, Flomenberg N, Keever-Taylor CA. Effect of T cell subset dose on outcome of T cell-depleted bone marrow transplantation. Bone Marrow Transplant. 1997 Jun; 19(11):1069-77. PMID: 9193748.
      Citations:    
    89. Keever-Taylor CA, Passweg J, Kawanishi Y, Casper J, Flomenberg N, Baxter-Lowe LA. Association of donor-derived host-reactive cytolytic and helper T cells with outcome following alternative donor T cell-depleted bone marrow transplantation. Bone Marrow Transplant. 1997 May; 19(10):1001-9. PMID: 9169644.
      Citations:    
    90. Szydlo R, Goldman JM, Klein JP, Gale RP, Ash RC, Bach FH, Bradley BA, Casper JT, Flomenberg N, Gajewski JL, Gluckman E, Henslee-Downey PJ, Hows JM, Jacobsen N, Kolb HJ, Lowenberg B, Masaoka T, Rowlings PA, Sondel PM, van Bekkum DW, van Rood JJ, Vowels MR, Zhang MJ, Horowitz MM. Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings. J Clin Oncol. 1997 May; 15(5):1767-77. PMID: 9164184.
      Citations:    
    91. Kawanishi Y, Flomenberg N, Cook-Craig A, McFadden P, Garbrecht F, Keever-Taylor CA. A new limiting dilution culture system for the detection of T cell subsets in T cell-depleted marrow grafts. J Hematother. 1996 Oct; 5(5):485-95. PMID: 8938520.
      Citations:    
    92. Margolis D, Camitta B, Pietryga D, Keever-Taylor C, Baxter-Lowe LA, Pierce K, Kupst MJ, French J, Truitt R, Lawton C, Murray K, Garbrecht F, Flomenberg N, Casper J. Unrelated donor bone marrow transplantation to treat severe aplastic anaemia in children and young adults. Br J Haematol. 1996 Jul; 94(1):65-72. PMID: 8757510.
      Citations:    
    93. Gilman A, Auger JJ, Terry L, Flomenberg N, Baxter-Lowe LA. HLA-B14 subtypes and their influence on allorecognition. Tissue Antigens. 1996 Mar; 47(3):253-6. PMID: 8740778.
      Citations:    
    94. Hessner MJ, Endean DJ, Casper JT, Horowitz MM, Keever-Taylor CA, Roth M, Flomenberg N, Drobyski WR. Use of unrelated marrow grafts compensates for reduced graft-versus-leukemia reactivity after T-cell-depleted allogeneic marrow transplantation for chronic myelogenous leukemia. Blood. 1995 Nov 15; 86(10):3987-96. PMID: 7579370.
      Citations:    
    95. LaFace DM, Vestberg M, Yang Y, Srivastava R, DiSanto J, Flomenberg N, Brown S, Sherman LA, Peterson PA. Human CD8 transgene regulation of HLA recognition by murine T cells. J Exp Med. 1995 Nov 1; 182(5):1315-25. PMID: 7595202.
      Citations:    
    96. Sarode R, McFarland JG, Flomenberg N, Casper JT, Cohen EP, Drobyski WR, Ash RC, Horowitz MM, Camitta B, Lawton C, et al. Therapeutic plasma exchange does not appear to be effective in the management of thrombotic thrombocytopenic purpura/hemolytic uremic syndrome following bone marrow transplantation. Bone Marrow Transplant. 1995 Aug; 16(2):271-5. PMID: 7581147.
      Citations:    
    97. Nemunaitis J, Rosenfeld CS, Ash R, Freedman MH, Deeg HJ, Appelbaum F, Singer JW, Flomenberg N, Dalton W, Elfenbein GJ, et al. Phase III randomized, double-blind placebo-controlled trial of rhGM-CSF following allogeneic bone marrow transplantation. Bone Marrow Transplant. 1995 Jun; 15(6):949-54. PMID: 7581096.
      Citations:    
    98. Keever CA, Abu-Hajir M, Graf W, McFadden P, Prichard P, O'Brien J, Flomenberg N. Characterization of the alloreactivity and anti-leukemia reactivity of cord blood mononuclear cells. Bone Marrow Transplant. 1995 Mar; 15(3):407-19. PMID: 7599566.
      Citations:    
    99. Castro-Malaspina H, Childs B, Laver J, Shank B, Brochstein J, Gillio A, Flomenberg N, Young J, Boulad F, Black P, et al. Hyperfractionated total lymphoid irradiation and cyclophosphamide for preparation of previously transfused patients undergoing HLA-identical marrow transplantation for severe aplastic anemia. Int J Radiat Oncol Biol Phys. 1994 Jul 1; 29(4):847-54. PMID: 8040033.
      Citations:    
    100. Gorski J, Yassai M, Zhu X, Kissela B, Kissella B [corrected to Kissela B], Keever C, Flomenberg N. Circulating T cell repertoire complexity in normal individuals and bone marrow recipients analyzed by CDR3 size spectratyping. Correlation with immune status. J Immunol. 1994 May 15; 152(10):5109-19. PMID: 8176227.
      Citations:    
    101. Cook-Craig A, Owen A, Reeder G, Drobyski W, Horowitz M, Brunner J, Flomenberg N, Keever C. Component processing and intraoperative autotransfusion during bone marrow harvest. Prog Clin Biol Res. 1994; 389:613-9. PMID: 7700927.
      Citations:    
    102. Drobyski WR, Dunne WM, Burd EM, Knox KK, Ash RC, Horowitz MM, Flomenberg N, Carrigan DR. Human herpesvirus-6 (HHV-6) infection in allogeneic bone marrow transplant recipients: evidence of a marrow-suppressive role for HHV-6 in vivo. J Infect Dis. 1993 Mar; 167(3):735-9. PMID: 8382723.
      Citations:    
    103. Young JW, Papadopoulos EB, Cunningham I, Castro-Malaspina H, Flomenberg N, Carabasi MH, Gulati SC, Brochstein JA, Heller G, Black P, et al. T-cell-depleted allogeneic bone marrow transplantation in adults with acute nonlymphocytic leukemia in first remission. Blood. 1992 Jun 15; 79(12):3380-7. PMID: 1596577.
      Citations:    
    104. Flomenberg N, Keever CA. Cord blood transplants: potential utility and potential limitations. Bone Marrow Transplant. 1992; 10 Suppl 1:115-20. PMID: 1521082.
      Citations:    
    105. Collins NH, Carabasi MH, Bleau S, Jagiello C, Young JW, Castro-Malaspina H, Flomenberg N, Papadopoulos EB, Emanuel D, Gillio A, et al. New technology for the depletion of T cells from soybean lectin agglutinated, HLA-matched bone marrow grafts for leukemia: initial laboratory and clinical results. Prog Clin Biol Res. 1992; 377:427-39. PMID: 1438441.
      Citations:    
    106. Small TN, Keever CA, Weiner-Fedus S, Heller G, O'Reilly RJ, Flomenberg N. B-cell differentiation following autologous, conventional, or T-cell depleted bone marrow transplantation: a recapitulation of normal B-cell ontogeny. Blood. 1990 Oct 15; 76(8):1647-56. PMID: 1698484.
      Citations:    
    107. Keever CA, Flomenberg N, Gazzola MV, Pekle K, Yang SY, Small TN, Collins NH, O'Reilly RJ. Cytotoxic and proliferative T-cell clones with antidonor reactivity from a patient transplanted for severe combined immunodeficiency disease. Hum Immunol. 1990 Sep; 29(1):42-55. PMID: 2211189.
      Citations:    
    108. Incefy GS, Flomenberg N, Heller G, Kernan NA, Brochstein J, Kirkpatrick D, Kapoor N, Groshen S, O'Reilly RJ. Evidence that appearance of thymulin in plasma follows lymphoid chimerism and precedes development of immunity in patients with lethal combined immunodeficiency transplanted with T cell-depleted haploidentical marrow. Transplantation. 1990 Jul; 50(1):55-61. PMID: 2368151.
      Citations:    
    109. Rosenkrantz K, Keever C, Bhimani K, Horvath A, Brochstein J, O'Reilly R, Dupont B, Flomenberg N. Both ongoing suppression and clonal elimination contribute to graft-host tolerance after transplantation of HLA mismatched T cell-depleted marrow for severe combined immunodeficiency. J Immunol. 1990 Mar 1; 144(5):1721-8. PMID: 2307837.
      Citations:    
    110. Bordignon C, Keever CA, Small TN, Flomenberg N, Dupont B, O'Reilly RJ, Kernan NA. Graft failure after T-cell-depleted human leukocyte antigen identical marrow transplants for leukemia: II. In vitro analyses of host effector mechanisms. Blood. 1989 Nov 1; 74(6):2237-43. PMID: 2529927.
      Citations:    
    111. Kernan NA, Bordignon C, Heller G, Cunningham I, Castro-Malaspina H, Shank B, Flomenberg N, Burns J, Yang SY, Black P, et al. Graft failure after T-cell-depleted human leukocyte antigen identical marrow transplants for leukemia: I. Analysis of risk factors and results of secondary transplants. Blood. 1989 Nov 1; 74(6):2227-36. PMID: 2804361.
      Citations:    
    112. Keever CA, Flomenberg N, Small T, Brochstein J, Collins N, Young-Yang S, Insel R, Dupont B, O'Reilly RJ. Loss of tolerance associated with disappearance of B cells in a patient sequentially transplanted with paternal and maternal bone marrow for the treatment of severe combined immunodeficiency disease. Hum Immunol. 1989 Sep; 26(1):27-38. PMID: 2528525.
      Citations:    
    113. Keever CA, Small TN, Flomenberg N, Heller G, Pekle K, Black P, Pecora A, Gillio A, Kernan NA, O'Reilly RJ. Immune reconstitution following bone marrow transplantation: comparison of recipients of T-cell depleted marrow with recipients of conventional marrow grafts. Blood. 1989 Apr; 73(5):1340-50. PMID: 2649174.
      Citations:    
    114. DiSanto JP, Klein JS, Flomenberg N. Phosphorylation and down-regulation of CD4 and CD8 in human CTLs and mouse L cells. Immunogenetics. 1989; 30(6):494-501. PMID: 2512251.
      Citations:    
    115. Gulati SC, Shank B, Sarris A, Berman E, Gee T, Cunningham I, Flomenberg N, O'Reilly RJ, Clarkson B. Autologous bone marrow transplant using 4-HC, VP-16 purged bone marrow for acute non-lymphoblastic leukemia. Bone Marrow Transplant. 1989 Jan; 4 Suppl 1:116-8. PMID: 2653485.
      Citations:    
    116. Keever CA, Flomenberg N, Brochstein J, Sullivan M, Collins NH, Burns J, Dupont B, O'Reilly RJ. Tolerance of engrafted donor T cells following bone marrow transplantation for severe combined immunodeficiency. Clin Immunol Immunopathol. 1988 Sep; 48(3):261-76. PMID: 3042210.
      Citations:    
    117. Kernan NA, Byers V, Scannon PJ, Mischak RP, Brochstein J, Flomenberg N, Dupont B, O'Reilly RJ. Treatment of steroid-resistant acute graft-vs-host disease by in vivo administration of an anti-T-cell ricin A chain immunotoxin. JAMA. 1988 Jun 3; 259(21):3154-7. PMID: 3285046.
      Citations:    
    118. Rosenkrantz K, Keever C, Kirsch J, Horvath A, Bhimani K, O'Reilly R, Dupont B, Flomenberg N. In vitro correlates of graft-host tolerance after HLA-matched and mismatched marrow transplants: suggestions from limiting dilution analysis. Transplant Proc. 1987 Dec; 19(6 Suppl 7):98-103. PMID: 3321650.
      Citations:    
    119. Dupont B, Flomenberg N, Yang SY. Alloantigens stimulating graft-v-host disease. Transplant Proc. 1987 Dec; 19(6 Suppl 7):48-51. PMID: 3424441.
      Citations:    
    120. O'Reilly RJ, Keever C, Kernan NA, Brochstein J, Collins N, Flomenberg N, Laver J, Emanuel D, Dupont B, Cunningham I, et al. HLA nonidentical T cell depleted marrow transplants: a comparison of results in patients treated for leukemia and severe combined immunodeficiency disease. Transplant Proc. 1987 Dec; 19(6 Suppl 7):55-60. PMID: 3321647.
      Citations:    
    121. Kernan NA, Flomenberg N, Dupont B, O'Reilly RJ. Graft rejection in recipients of T-cell-depleted HLA-nonidentical marrow transplants for leukemia. Identification of host-derived antidonor allocytotoxic T lymphocytes. Transplantation. 1987 Jun; 43(6):842-7. PMID: 3296349.
      Citations:    
    122. O'Reilly RJ, Collins N, Dinsmore R, Kernan N, Siena S, Brochstein J, Kirkpatrick D, Flomenberg N, Shank B, Dupont B, et al. Transplantation of HLA-mismatched marrow depleted of T-cells by lectin agglutination and E-rosette depletion. Tokai J Exp Clin Med. 1985 Jun; 10(2-3):99-107. PMID: 3914748.
      Citations:    
    123. O'Reilly RJ, Kirkpatrick D, Kapoor N, Collins N, Brochstein J, Kernan N, Flomenberg N, Pollack M, Dupont B, Lopez C, et al. A comparative review of the results of transplants of fully allogeneic fetal liver and HLA-haplotype mismatched, T-cell depleted marrow in the treatment of severe combined immunodeficiency. Prog Clin Biol Res. 1985; 193:327-42. PMID: 3911216.
      Citations:    
    124. Flomenberg N, Knowles RW, Williams D, Horibe K, Rosenkrantz K, Dupont B. T lymphocyte clones detecting novel supertypic HLA class II allospecificities. Immunogenetics. 1985; 22(3):295-300. PMID: 2412958.
      Citations:    
    125. Dinsmore R, Kirkpatrick D, Flomenberg N, Gulati S, Kapoor N, Brochstein J, Shank B, Reid A, Groshen S, O'Reilly RJ. Allogeneic bone marrow transplantation for patients with acute nonlymphocytic leukemia. Blood. 1984 Mar; 63(3):649-56. PMID: 6365204.
      Citations:    
    126. Flomenberg N, Dupont B, O'Reilly RJ, Hayward A, Pollack MS. The use of T cell culture techniques to establish the presence of an intrauterine-derived maternal T cell graft in a patient with severe combined immunodeficiency (SCID). Transplantation. 1983 Dec; 36(6):733-5. PMID: 6606881.
      Citations:    
    127. Dinsmore R, Kirkpatrick D, Flomenberg N, Gulati S, Kapoor N, Shank B, Reid A, Groshen S, O'Reilly RJ. Allogeneic bone marrow transplantation for patients with acute lymphoblastic leukemia. Blood. 1983 Aug; 62(2):381-8. PMID: 6347274.
      Citations:    
    128. O'Reilly RJ, Kapoor N, Kirkpatrick D, Flomenberg N, Pollack MS, Dupont B, Good RA, Reisner Y. Transplantation of hematopoietic cells for lethal congenital immunodeficiencies. Birth Defects Orig Artic Ser. 1983; 19(3):129-37. PMID: 6140037.
      Citations:    
    129. Welte K, Venuta S, Wang CY, Feldman SP, Ciobanu N, Kruger G, Feickert HJ, Merluzzi VJ, Flomenberg N, Moore MA, Mertelsmann R. Human interleukin 2: physiology, biochemistry, and pathophysiology in lymphoblastic leukemias and immunodeficiency syndromes. Haematol Blood Transfus. 1983; 28:369-79. PMID: 6602744.
      Citations:    
    130. Dupont B, Flomenberg N, O'Reilly RJ. Bone marrow transplantation for correction of severe aplastic anemia and primary immunodeficiency. Ann Clin Res. 1981; 13(4-5):358-66. PMID: 7039487.
      Citations:    
    Flomenberg's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (489)
    Explore
    _
    Co-Authors (66)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _